Work

Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist

Year: 2022

Type: review

Source: Journal of Diabetes and its Complications

DOI: 10.1016/j.jdiacomp.2022.108332

Authors: Shasta Tall Bull, Wesley Nuffer, Jennifer M. Trujillo

Institution: University of Colorado System

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4302024172

FWCI: 0.97

Cites: 31

Cited by: 43

Related to: 10